CollPlant Biotechnologies
CLGNCollPlant Biotechnologies (NASDAQ: CLGN) is an Israel-based regenerative medicine company focused on the development and manufacturing of recombinant human collagen (rhCollagen) and related products. The company's proprietary plant-based biotechnology platform utilizes genetically engineered tobacco plants to produce Type I and Type III human collagen. This rhCollagen serves as a key biomaterial for advanced medical applications, including 3D bioprinting of tissues and organs, and the creation of soft and hard tissue regeneration products. The company's product pipeline and commercial offerings are centered on its core rhCollagen technology. Key areas of application include dermal fillers for aesthetic medicine, wound care matrices for the treatment of complex wounds, and bio-inks for 3D bioprinting in partnership with other biotechnology firms. CollPlant's manufacturing facility in Rehovot, Israel, produces the rhCollagen under Good Manufacturing Practice (GMP) standards for both internal development and commercial supply to third-party customers in the medical and research sectors.
CLGN · Stock Price
Historical price data
About
CollPlant Biotechnologies (NASDAQ: CLGN) is an Israel-based regenerative medicine company focused on the development and manufacturing of recombinant human collagen (rhCollagen) and related products. The company's proprietary plant-based biotechnology platform utilizes genetically engineered tobacco plants to produce Type I and Type III human collagen. This rhCollagen serves as a key biomaterial for advanced medical applications, including 3D bioprinting of tissues and organs, and the creation of soft and hard tissue regeneration products. The company's product pipeline and commercial offerings are centered on its core rhCollagen technology. Key areas of application include dermal fillers for aesthetic medicine, wound care matrices for the treatment of complex wounds, and bio-inks for 3D bioprinting in partnership with other biotechnology firms. CollPlant's manufacturing facility in Rehovot, Israel, produces the rhCollagen under Good Manufacturing Practice (GMP) standards for both internal development and commercial supply to third-party customers in the medical and research sectors.